MLYS
Mineralys Therapeutics, Inc. Common Stock
NASDAQ: MLYS · HEALTHCARE · BIOTECHNOLOGY
$25.56
-1.27% today
Updated 2026-04-29
Market cap
$2.11B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.29
Dividend yield
—
52W range
$13 – $48
Volume
1.2M
Mineralys Therapeutics, Inc. Common Stock (MLYS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-2.46M | $-14.56M | $-29.22M | $-81.17M | $-166.31M | $-142.42M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $0.00 | $96000.00 | $15000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $1000.00 | $80000.00 | $455000.00 | $5.06M | $11.34M | $19.32M |
| Free cash flow | $-2.46M | $-14.56M | $-29.22M | $-81.17M | $-166.41M | $-142.43M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | $3.83M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |